
Towards a dendritic cell-based vaccine for the treatment of multiple sclerosis (MS): interim safety data of the first dose cohort of the MS-tolDC phase I clinical trial
Author(s) -
Nathalie Cools,
Silvia Presas-Rodríguez,
María José Mansilla,
Judith Derdelinckx,
Wai Ping Lee,
Griet Nijs,
Maxime De Laere,
Inez Wens,
Patrick Cras,
Paul M. Parizel,
Wim Van Hecke,
Annemie Ribbens,
Geert Adams,
Marie-Madeleine Couttenye,
Juan NavarroBarriuso,
Aina TenienteSerra,
Bibiana QuirantSánchez,
Ascensión LópezDíaz de Cerio,
Susana Inogés,
Felipe Prósper,
Catharina C. Groß,
Heinz Wiendl,
S. Marieke van Ham,
Anja ten Brinke,
Herman Verheij,
Anke E Kip,
Ana Marian Barriocanal,
Anna Massuet-Vilamajó,
Niel Hens,
Zwi Berneman,
Eva Martı́nez-Cáceres,
Cristina RamoTello,
Barbara Willekens
Publication year - 2018
Publication title -
frontiers in neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.499
H-Index - 102
eISSN - 1662-4548
pISSN - 1662-453X
DOI - 10.3389/conf.fnins.2018.95.00060
Subject(s) - multiple sclerosis , interim , cohort , medicine , interim analysis , clinical trial , oncology , immunology , archaeology , history